Essential to society and economy but facing “rough waters”
The pharmaceutical industry has experienced a remarkable upswing in recent years: massive investments in research and production, technological breakthroughs in innovative therapies, and a new momentum in healthcare delivery. But in 2026, the industry stands at a crossroads.
Europe is moving in a rapid reform rhythm with the Pharma Package, EU HTA, EHDS, and AI framework regulations. At the same time, Germany’s Medical Research Act is beginning to show its effects….
